Official Ministry of Health statistics show that the COVID-19 pandemic is rapidly becoming one of the vaccinated.
Should the people of New Zealand be demanding a full refund from Pfizer of the hundreds of millions spent on buying its faulty mRNA product?
Recent data shows the number of COVID-19 hospitalisation cases are primarily made up of those who are fully vaccinated. With traditional vaccines, it is the opposite – hospitalisation rates are much higher in those who are unvaccinated.
An important point to consider first is how does the government determine vaccination percentage rates for each region?
According to the MOH, population numbers of each region are determined by ‘HSU estimates’, the ‘Health Service User’ estimates. Vaccination rates are not based on actual population statistics, but on the number of people who interacted with the DHB in the previous year, as explained recently by MidCentral Health, when they were caught out claiming a 100% vaccination rate.
The Auckland region has a population of 1.7 million people and its DHBs a 97% vaccination rate. If only 1 million of those interacted with the DHBs in the previous 12 months, does this mean that the vaccination rate for Auckland is 97% of 1 million, rather than 97% of 1.7 million?
That is an exreme example, but the methodolgy in determining regional vaccination rates raises questions about accuracy of vaccination rate calculation and whether that percentage is smaller than what we are being told. If it is smaller, then it makes the claim ‘pandemic of the vaccinated’ even more valid because the number of unvaccinated is likely to be higher than what is being portrayed by the government and legacy mainstream media.
Comparing the Pfizer mRNA medication with traditional vaccines, well, there is no comparison.
For the period 25 January to 16 February 2022, 86% of hospitalised COVID-19 cases were vaccinated.
In the 2019 measels outbreak, only 6.4% of hospitalised cases were vaccinated.
Of the hospitalised cases for pertussis in 2018, 49% were unvaccinated.
There have been no polio hospitalisation cases in New Zealand since 1961 when the vaccine for that disease was introduced.
Apart from the issue of hospitalisations, the Pfizer mRNA medication does not prevent transmission or infection. The most ‘vaccinated’ countries are seeing an explosion in infections – Israel is one often-cited example, but the evidence is showing the more vaxxed a country is, the more problems it has with COVID.
The New Zealand taxpayer has paid Pfizer a vast amount of money for a product which does not prevent transmission, or infection, and which does the opposite of what traditional vaccines do in terms of reducing the hospitalisation rate. The product is not fit for purpose.
Pfizer also has immunity from paying compensation to those suffering injury or death from its product, nor has it any liability for side-effects that will only become apparent in the population in the long-term.